HomeLatest NewsCovid-19FDA Alerts Providers to COVID-19 Rapid Test Recall

FDA Alerts Providers to COVID-19 Rapid Test Recall

The Food and Drug Administration announced a Class 1 recall of the E25Bio COVID-19 Direct Antigen Response Test. E25Bio is recalling its COVID-19 Direct Antigen Response Tests (DART) for several reasons, particularly that these tests were marketed and distributed to U.S. customers without authorization, clearance, or approval from the FDA. Labeling distributed with some of the tests also includes inaccurate claims and instructions, including a statement that misrepresents the test as FDA-authorized.

Due to the potential for false results, the FDA said health care providers who administered the test in the past two weeks and suspect an inaccurate result should consider retesting patients with an authorized test.

Click here for further details.

Stay Connected

Unified Voice Newsletter

Events This Month

march

28mar11:30 am12:30 pmEVIDENCE-BASED ADVOCACY FOR THE HOSPICE AND PALLIATIVE CARE CLINICIANMJHS Hospice and Palliative Care Webinar


By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact